446
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices

, , &

References

  • Arfken, C. L., & Balon, R. ( 2011). Declining participation in research studies. [Editorial]. Psychotherapy and Psychosomatics, 80(6), 325–328. doi:10.1159/000324795
  • Bart, G. ( 2012). Maintenance medication for opiate addiction: the foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225. doi:10.1080/10550887.2012.694598
  • Betty Ford Institute Consensus Panel. (2007). What is recovery? A working definition from the Betty Ford Institute. Journal of Substance Abuse Treatment, 33, 221–228.
  • Boyer, P. ( 2003). Religious thought and behaviour as by-products of brain function. Trends in Cognitive Sciences, 7(3), 119–124.
  • Centers for Disease Control and Prevention. ( 2012). CDC grand rounds: Prescription drug overdoses - a U.S. epidemic. Morbidity and Mortality Weekly Report, 61(1), 10–13.
  • Corrigan, P. W., & Penn, D. L. ( 1999). Lessons from social psychology on discrediting psychiatric stigma. American Psychologist, 54(9), 765–776.
  • Crapanzano, K., Vath, R. J., & Fisher, D. ( 2014). Reducing stigma towards substance users through an educational intervention: harder than it looks. Acad Psychiatry, 38(4), 420–425. doi:10.1007/s40596–014–0067–1
  • Gerra, G., Leonardi, C., D’Amore, A., Strepparola, G., Fagetti, R., Assi, C.,… Lucchini, A. ( 2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in Neuro-Psychopharmacology & Biological Psychiatry , 30(2), 265–272.
  • Hser, Y. I., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M.,… Ling, W. ( 2014). Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction, 109(1), 79–87. doi:10.1111/add.12333
  • Kay, A. C., Gaucher, D., McGregor, I., & Nash, K. ( 2010). Religious belief as compensatory control. Personality and Social Psychology Review, 14(1), 37–48. doi:10.1177/1088868309353750
  • Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E.,… Zaslavsky, A. M. ( 2005). Prevalence and treatment of mental disorders, 1990 to 2003. The New England Journal of Medicine, 352(24), 2515–2523.
  • Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M.,… Wyatt, S. A. ( 2011). Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Journal of Addiction Medicine, 5(4), 254–263. doi:10.1097/ADM.0b013e3182312983
  • Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. ( 2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107(1), 39–50. doi:10.1111/j.1360–0443.2011.03601.x
  • Mark, T. L., Dilonardo, J., Vandivort, R., & Miller, K. ( 2013). Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine. Journal of Substance Abuse Treatment, 44(5), 481–487. doi:10.1016/j.jsat.2012.11.004
  • National Center on Addiction and Substance Abuse at Columbia University. (2000). Missed opportunity: National survey of primary care physicians and patients on substance abuse. Retrieved from http://www.casacolumbia.org/addiction-research/reports/national-survey-primary-care-physicians-patients-substance-abuse
  • National Center on Addiction and Substance Abuse at Columbia University. (2012). Addiction medicine: Closing the gap between science and practice. Retrieved from http://www.casacolumbia.org/upload/2012/20120626addictionmed.pdf
  • National Institute on Drug Abuse. ( 2014). Prescription and Over-the-Counter Medications. Retrieved from http://www.drugabuse.gov/publications/research-reports/prescription-drugs
  • Olsen, Y., & Sharfstein, J. M. ( 2014). Confronting the stigma of opioid use disorder–and its treatment. Journal of the American Medical Association, 311(14), 1393–1394. doi:10.1001/jama.2014.2147
  • Parran, T. V., Adelman, C. A., Merkin, B., Pagano, M. E., Defranco, R., Ionescu, R. A., & Mace, A. G. ( 2010). Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug and Alcohol Dependence, 106(1), 56–60. doi:10.1016/j.drugalcdep.2009.07.013
  • Quest, T. L., Merrill, J. O., Roll, J., Saxon, A. J., & Rosenblatt, R. A. ( 2012). Buprenorphine therapy for opioid addiction in rural Washington: The experience of the early adopters. Journal of Opioid Management, 8(1), 29–38.
  • Schuman-Olivier, Z., Connery, H., Griffin, M. L., Wyatt, S. A., Wartenberg, A. A., Borodovsky, J.,… Weiss, R. D. ( 2013). Clinician beliefs and attitudes about buprenorphine/naloxone diversion. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 22(6), 574–580. doi:10.1111/j.1521–0391.2013.12024.x
  • Sinclair, M., O’Toole, J., Malawaraarachchi, M., & Leder, K. ( 2012). Comparison of response rates and cost-effectiveness for a community-based survey: postal, internet and telephone modes with generic or personalised recruitment approaches. BMC Medical Research Methodology, 12, 132. doi:10.1186/1471–2288–12–132.
  • Thomas, C. P., Fullerton, C. A., Kim, M., Montejano, L., Lyman, D. R., Dougherty, R. H.,… Delphin-Rittmon, M. E. ( 2014). Medication-assisted treatment with buprenorphine: Assessing the evidence. Psychiatric Services, 65(2), 158–170. doi:10.1176/appi.ps.201300256
  • van Boekel, L. C., Brouwers, E. P., van Weeghel, J., & Garretsen, H. F. ( 2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131(1-2), 23–35. doi:10.1016/j.drugalcdep.2013.02.018
  • White, W. L. ( 2012). Medication-assisted recovery from opioid addiction: historical and contemporary perspectives. Journal of Addictive Diseases, 31(3), 199–206. doi:10.1080/10550887.2012.694597

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.